HEPATIC ENCEPHALOPATHY
Clinical trials for HEPATIC ENCEPHALOPATHY explained in plain language.
Never miss a new study
Get alerted when new HEPATIC ENCEPHALOPATHY trials appear
Sign up with your email to follow new studies for HEPATIC ENCEPHALOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug formulation aims to prevent brain fog in liver disease patients
Disease control OngoingThis study tests a new version of the drug rifaximin (called SSD) to see if it can delay the first episode of a serious brain complication (hepatic encephalopathy) in people with liver cirrhosis who have fluid buildup (ascites) controlled by medication. About 466 adults aged 18-8…
Matched conditions: HEPATIC ENCEPHALOPATHY
Phase: PHASE3 • Sponsor: Bausch Health Americas, Inc. • Aim: Disease control
Last updated May 17, 2026 05:24 UTC
-
Could a poop transplant clear the fog of liver disease?
Disease control OngoingThis study tests whether transplanting gut bacteria from healthy donors can help people with advanced liver disease who suffer from confusion (hepatic encephalopathy). Researchers will first find the best stool donors, then compare the transplant to a placebo in 30 patients. The …
Matched conditions: HEPATIC ENCEPHALOPATHY
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Apr 26, 2026 19:36 UTC
-
New tool could predict brain risks after liver shunt surgery
Knowledge-focused OngoingThis study looks back at medical records of 624 people with liver cirrhosis who had a procedure called TIPS to relieve pressure in the liver. The goal is to create a simple tool that helps doctors predict which patients are at high risk for a brain complication called hepatic enc…
Matched conditions: HEPATIC ENCEPHALOPATHY
Sponsor: The Second Affiliated Hospital of Chongqing Medical University • Aim: Knowledge-focused
Last updated May 01, 2026 15:58 UTC